BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 24256629)

  • 21. Post-HAART tuberculosis in adults and adolescents with HIV in India: incidence, clinical and immunological profile.
    Rajasekaran S; Raja K; Jeyaseelan L; Vijilat S; Priya K; Mohan K; Parvez A; Mahilmaran A; Chandrasekar C
    Indian J Tuberc; 2009 Apr; 56(2):69-76. PubMed ID: 19810588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of highly active antiretroviral treatment on TB incidence among HIV infected children and their clinical profile, retrospective cohort study, South West Ethiopia.
    Tiruneh F; Deyas Y
    Sci Rep; 2020 Dec; 10(1):21468. PubMed ID: 33293656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extensively drug-resistant tuberculosis in children with human immunodeficiency virus in rural South Africa.
    Thomas TA; Shenoi SV; Heysell SK; Eksteen FJ; Sunkari VB; Gandhi NR; Friedland G; Shah NS
    Int J Tuberc Lung Dis; 2010 Oct; 14(10):1244-51. PubMed ID: 20843414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integration and task shifting for TB/HIV care and treatment in highly resource-scarce settings: one size may not fit all.
    Van Rie A; Patel MR; Nana M; Vanden Driessche K; Tabala M; Yotebieng M; Behets F
    J Acquir Immune Defic Syndr; 2014 Mar; 65(3):e110-7. PubMed ID: 24091692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of HAART initiation timing on HIV-TB co-infected patients, a retrospective cohort study.
    Yang CH; Chen KJ; Tsai JJ; Lin YH; Cheng SH; Wang KF; Chiou HY
    BMC Infect Dis; 2014 Jun; 14():304. PubMed ID: 24897928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of HIV status and antiretroviral treatment on treatment outcomes of tuberculosis patients in a rural primary healthcare clinic in South Africa.
    Nyasulu PS; Ngasama E; Tamuzi JL; Sigwadhi LN; Ozougwu LU; Nhandara RBC; Ayele BT; Umanah T; Ncayiyana J
    PLoS One; 2022; 17(10):e0274549. PubMed ID: 36223365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does immune reconstitution syndrome promote active tuberculosis in patients receiving highly active antiretroviral therapy?
    Breen RA; Smith CJ; Cropley I; Johnson MA; Lipman MC
    AIDS; 2005 Jul; 19(11):1201-6. PubMed ID: 15990574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Timing of Antiretroviral Treatment, Immunovirologic Status, and TB Risk: Implications for Testing and Treatment.
    Pettit AC; Mendes A; Jenkins C; Napravnik S; Freeman A; Shepherd BE; Dowdy D; Gill J; Rachlis A; Moore R; Sterling TR;
    J Acquir Immune Defic Syndr; 2016 Aug; 72(5):572-8. PubMed ID: 27049511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort.
    Lawn SD; Badri M; Wood R
    AIDS; 2005 Dec; 19(18):2109-16. PubMed ID: 16284460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of tuberculosis and early mortality in a large cohort of HIV infected patients receiving antiretroviral therapy in a tertiary hospital in Addis Ababa, Ethiopia.
    Kassa A; Teka A; Shewaamare A; Jerene D
    Trans R Soc Trop Med Hyg; 2012 Jun; 106(6):363-70. PubMed ID: 22521216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tuberculosis incidence rate and risk factors among HIV-infected adults with access to antiretroviral therapy.
    Liu E; Makubi A; Drain P; Spiegelman D; Sando D; Li N; Chalamilla G; Sudfeld CR; Hertzmark E; Fawzi WW
    AIDS; 2015 Jul; 29(11):1391-9. PubMed ID: 26091295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort.
    Golub JE; Pronyk P; Mohapi L; Thsabangu N; Moshabela M; Struthers H; Gray GE; McIntyre JA; Chaisson RE; Martinson NA
    AIDS; 2009 Mar; 23(5):631-6. PubMed ID: 19525621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Worsening and unmasking of tuberculosis in HIV-1 infected patients after initiating highly active anti-retroviral therapy in Uganda.
    Baalwa J; Mayanja-Kizza H; Kamya MR; John L; Kambugu A; Colebunders R
    Afr Health Sci; 2008 Sep; 8(3):190-5. PubMed ID: 19357749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Markov model for the effects of virological failure on HIV/AIDS progression in tuberculosis co-infected patients receiving antiretroviral therapy in a rural clinic in northern South Africa.
    Shoko C; Chikobvu D; Bessong PO
    S Afr Med J; 2020 Mar; 110(4):313-319. PubMed ID: 32657744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of CD4/CD8 ratio on the incidence of tuberculosis in HIV-infected patients on antiretroviral therapy followed up for more than a decade.
    Wolday D; Kebede Y; Legesse D; Siraj DS; McBride JA; Kirsch MJ; Striker R
    PLoS One; 2020; 15(5):e0233049. PubMed ID: 32442166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Initiation of antiretroviral therapy in HIV-infected tuberculosis patients in rural Kenya: an observational study.
    Stockdale AJ; Nkuranga J; Török ME; Faragher B; Lalloo DG
    Trop Med Int Health; 2013 Jul; 18(7):907-14. PubMed ID: 23590229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in sub-Saharan Africa.
    Hermans SM; Kiragga AN; Schaefer P; Kambugu A; Hoepelman AI; Manabe YC
    PLoS One; 2010 May; 5(5):e10527. PubMed ID: 20479873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tuberculosis prevalence, incidence and prevention in a south african cohort of children living with HIV.
    Anyalechi GE; Bain R; Kindra G; Mogashoa M; Sogaula N; Mutiti A; Arpadi S; Rivadeneira E; Abrams EJ; Teasdale CA
    J Trop Pediatr; 2022 Oct; 68(6):. PubMed ID: 36269203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tuberculosis among HIV-infected population: incidence and risk factors in rural Tanzania.
    Said K; Verver S; Kalingonji A; Lwilla F; Mkopi A; Charalambous S; Reither K
    Afr Health Sci; 2017 Mar; 17(1):208-215. PubMed ID: 29026395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Clinical Algorithm to Identify HIV Patients at High Risk for Incident Active Tuberculosis: A Prospective 5-Year Cohort Study.
    Lee SS; Lin HH; Tsai HC; Su IJ; Yang CH; Sun HY; Hung CC; Sy CL; Wu KS; Chen JK; Chen YS; Fang CT
    PLoS One; 2015; 10(8):e0135801. PubMed ID: 26280669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.